Genomic instability in bone marrow failure syndromes

American Journal of Hematology
William G KearnsJohnson M Liu

Abstract

Aneuploidy is frequently seen in leukemia and myelodysplasia (MDS) but was thought to be uncommon in aplastic anemia (AA). We examined marrow cells from 96 unselected patients with bone marrow failure syndromes to assess the frequency of undetected aneuploidy for chromosomes 7 and 8 by fluorescence in situ hybridization (FISH) as compared to routine cytogenetic analysis. Twenty-eight percent (27/96) of patients had an abnormal karyotype. FISH identified an additional 27 patients with undetected monosomy 7 or trisomy 8. Those patients with undetected monosomy 7 generally had a poor clinical outcome, suffering from lack of response to medical therapy or early death. In one AA/MDS patient with normal cytogenetics, FISH identified a large population of monosomy 7 cells, which clearly heralded a clinical relapse. In another patient, FISH studies were used to delineate instability of chromosome 8, with apparent disease progression from AA to MDS. We conclude that undetected aneuploidy exists in marrow cells of a significant percentage of patients with bone marrow failure syndromes.

References

Apr 1, 1995·Annals of Hematology·D HaaseE Lengfelder
May 30, 1998·Journal of Assisted Reproduction and Genetics·R H Martin
Apr 3, 2001·American Journal of Hematology·Y K KeungD H Buss
Mar 8, 2003·JAMA : the Journal of the American Medical Association·Stephen RosenfeldNeal S Young

❮ Previous
Next ❯

Citations

Mar 1, 2009·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Payal TripathiAchchhe Lal Vishwakerma
May 12, 2005·Blood Reviews·Daniel V T Catenacci, Gary J Schiller
Sep 19, 2006·Proceedings of the National Academy of Sciences of the United States of America·Elaine M SloandNeal S Young
Mar 31, 2009·Hematology/oncology Clinics of North America·Grover C Bagby, Gabrielle Meyers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.